{{Rsnum
|rsid=4389526
|Gene=ANTXR2
|Chromosome=4
|position=80025321
|Orientation=plus
|GMAF=0.3471
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;T)
|geno3=(T;T)
|Gene_s=ANTXR2
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;T)
| geno3=(T;T)
| CEU | 26.2 | 55.4 | 18.5
| HCB | 91.1 | 8.9 | 0.0
| JPT | 91.1 | 8.9 | 0.0
| YRI | 4.8 | 42.9 | 52.4
| ASW | 0.0 | 0.0 | 0.0
| CHB | 91.1 | 8.9 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=21743469
|Trait=None
|Title=Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility.
|RiskAllele=A
|Pval=9E-8
|OR=None
|ORtxt=None
|OA=1
}}